PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Translational Immunology, Health and Sports Sciences Center, Federal University of Acre, Rio Branco 69920-900, Brazil.\', \'Laboratory of Molecular Exercise Physiology, University Center UDF, Brasília 70390-045, Brazil.\', \'Laboratory of Immunoparasitology \'Dr. Mário Endsfeldz Camargo\', Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405-317, Brazil.\', \'Laboratory on Thymus Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro 21040-900, Brazil.\', \'National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Rio de Janeiro 21040-900, Brazil.\', \'Laboratory of Allergy and Clinical Immunology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia 38405-317, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • 185310.3390/ijerph19031853
?:doi
?:hasPublicationType
?:journal
  • International journal of environmental research and public health
is ?:pmid of
?:pmid
?:pmid
  • 35162875
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.735
?:rankingScore_hIndex
  • 67
is ?:relation_isRelatedTo_publication of
?:title
  • Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all